We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-18.45%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$2.12B
AUM Growth
+$287M
Cap. Flow
+$729M
Cap. Flow %
34.43%
Top 10 Hldgs %
10.68%
Holding
2,455
New
598
Increased
849
Reduced
552
Closed
442

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$70.1M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$17M
3
CNC icon
Centene
CNC
+$11.6M
4
NVDA icon
NVIDIA
NVDA
+$11.5M
5
ADNT icon
Adient
ADNT
+$10.8M

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$15.4M
2
VRSN icon
VeriSign
VRSN
+$14M
3
UAL icon
United Airlines
UAL
+$13.5M
4
JNJ icon
Johnson & Johnson
JNJ
+$10.4M
5
WCG
Wellcare Health Plans, Inc.
WCG
+$10M

Sector Composition

Rank Sector Weight
1 Technology 16.77%
2 Financials 12.38%
3 Healthcare 11.71%
4 Industrials 11.7%
5 Consumer Discretionary 10.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LJPC
1776
DELISTED
La Jolla Pharmaceutical Company
LJPC
$90K ﹤0.01%
9,548
+9,499
+19,386% +$143K
BTG icon
1777
B2Gold
BTG
$6.7B
$89K ﹤0.01%
30,552
-123,548
-80% -$321K
SM icon
1778
SM Energy
SM
$6.92B
$89K ﹤0.01%
5,771
-13,596
-70% -$314K
NEX
1779
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$89K ﹤0.01%
10,940
-18,252
-63% -$204K
VRS
1780
DELISTED
Verso Corporation
VRS
$89K ﹤0.01%
3,955
-8,958
-69% -$242K
ADAP
1781
DELISTED
Adaptimmune Therapeutics
ADAP
$88K ﹤0.01%
15,233
+3,492
+30% +$25.8K
ADVM
1782
DELISTED
Adverum Biotechnologies
ADVM
$88K ﹤0.01%
+2,784
New +$113K
OPCH icon
1783
Option Care Health
OPCH
$3.56B
$88K ﹤0.01%
+6,161
New +$81.2K
ACAD icon
1784
Acadia Pharmaceuticals
ACAD
$5.03B
$87K ﹤0.01%
5,378
-22,566
-81% -$438K
WWD icon
1785
Woodward
WWD
$21.4B
$87K ﹤0.01%
1,175
+341
+41% +$26.3K
LLY icon
1786
Eli Lilly
LLY
$1.06T
$86K ﹤0.01%
744
-23,345
-97% -$2.61M
NVT icon
1787
nVent Electric
NVT
$26.7B
$86K ﹤0.01%
3,835
+2,441
+175% +$59.1K
XPRO icon
1788
Expro Ltd
XPRO
$1.91B
$86K ﹤0.01%
2,760
-6,242
-69% -$271K
DNR
1789
DELISTED
Denbury Resources, Inc.
DNR
$86K ﹤0.01%
50,312
+7,260
+17% +$25K
DRH icon
1790
Diamondrock Hospitality Co
DRH
$2.56B
$84K ﹤0.01%
9,282
-52,538
-85% -$542K
FOLD
1791
DELISTED
Amicus Therapeutics
FOLD
$84K ﹤0.01%
8,758
-3,432
-28% -$37.7K
FSP
1792
Franklin Street Properties
FSP
$46.8M
$83K ﹤0.01%
+13,338
New +$98K
CHS
1793
DELISTED
Chicos FAS, Inc.
CHS
$83K ﹤0.01%
14,826
-9,051
-38% -$63K
ROL icon
1794
Rollins
ROL
$18.2B
$82K ﹤0.01%
3,392
-39,860
-92% -$1.03M
CAJ
1795
DELISTED
Canon, Inc.
CAJ
$82K ﹤0.01%
+2,957
New +$85.7K
TNDM icon
1796
Tandem Diabetes Care
TNDM
$1.53B
$81K ﹤0.01%
2,131
-9,966
-82% -$352K
VSTM icon
1797
Verastem
VSTM
$592M
$81K ﹤0.01%
+2,004
New +$122K
BCRX icon
1798
BioCryst Pharmaceuticals
BCRX
$2.4B
$80K ﹤0.01%
9,937
-7,957
-44% -$61.9K
EDIT icon
1799
Editas Medicine
EDIT
$442M
$80K ﹤0.01%
3,532
+200
+6% +$5.44K
CPE
1800
DELISTED
Callon Petroleum Company
CPE
$79K ﹤0.01%
1,213
-195
-14% -$18.8K
70 71
72
73 74

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q4 2018 Portfolio in Review

As of Q4 2018, Cubist Systematic Strategies held 2,455 positions worth $2.12B, up 16% from $1.83B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Cubist Systematic Strategies deployed $729M of net new capital in Q4 2018, opening 598 new positions and adding to 849 existing holdings. Its largest new stake was Walgreens Boots Alliance: 113,965 shares worth $7.79M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was NXP Semiconductors, an estimated $15.4M trimmed.

  • Cubist Systematic Strategies's largest Q4 2018 buy was Walgreens Boots Alliance: 113,965 shares worth $7.79M.
  • Cubist Systematic Strategies added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $70.1M increase.
  • Cubist Systematic Strategies's biggest Q4 2018 reduction was NXP Semiconductors, cutting an estimated $15.4M.
  • Cubist Systematic Strategies fully exited Wellcare Health Plans, Inc. in Q4 2018, selling an estimated $10M.
  • Cubist Systematic Strategies's ten largest holdings make up 11% of its $2.12B portfolio in Q4 2018.
  • Cubist Systematic Strategies opened 598 new positions and closed 442 in Q4 2018.
  • Cubist Systematic Strategies's portfolio value rose 16% quarter-over-quarter to $2.12B.

Based on Cubist Systematic Strategies's 13F filing for Q4 2018, filed 14 Feb 2019.